<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Veris Limited — News on 6ix</title>
<link>https://6ix.com/company/veris-ltd</link>
<description>Latest news and press releases for Veris Limited on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 04:24:04 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/veris-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo683669fe78dffbe2df15f54d.webp</url>
<title>Veris Limited</title>
<link>https://6ix.com/company/veris-ltd</link>
</image>
<item>
<title>Veris Appointed Octave's Geospatial Solutions Distributor</title>
<link>https://6ix.com/company/veris-ltd/news/veris-appointed-octaves-geospatial-solutions-distributor</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/veris-appointed-octaves-geospatial-solutions-distributor</guid>
<pubDate>Tue, 14 Apr 2026 04:24:04 GMT</pubDate>
<description>Veris Appointed Octave's Geospatial Solutions Distributor</description>
</item>
<item>
<title>PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results</title>
<link>https://6ix.com/company/veris-ltd/news/pavmed-provides-business-update-and-reports-fourth-quarter-and-full-year-2025-financial-results-2</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/pavmed-provides-business-update-and-reports-fourth-quarter-and-full-year-2025-financial-results-2</guid>
<pubDate>Mon, 30 Mar 2026 12:00:00 GMT</pubDate>
<description>PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and reported financial results for the fourth quarter and year ended December 31, 2025.</description>
</item>
<item>
<title>VRS Investor Presentation - Microcaps HY Result Presentation</title>
<link>https://6ix.com/company/veris-ltd/news/vrs-investor-presentation-microcaps-hy-result-presentation</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/vrs-investor-presentation-microcaps-hy-result-presentation</guid>
<pubDate>Fri, 27 Feb 2026 02:28:32 GMT</pubDate>
<description>VRS Investor Presentation - Microcaps HY Result Presentation</description>
</item>
<item>
<title>FY26 H1 Appendix 4D</title>
<link>https://6ix.com/company/veris-ltd/news/fy26-h1-appendix-4d</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/fy26-h1-appendix-4d</guid>
<pubDate>Tue, 24 Feb 2026 02:34:33 GMT</pubDate>
<description>FY26 H1 Appendix 4D</description>
</item>
<item>
<title>Veris Ltd - FY26 H1 Results Presentation</title>
<link>https://6ix.com/company/veris-ltd/news/veris-ltd-fy26-h1-results-presentation</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/veris-ltd-fy26-h1-results-presentation</guid>
<pubDate>Tue, 24 Feb 2026 02:34:32 GMT</pubDate>
<description>Veris Ltd - FY26 H1 Results Presentation</description>
</item>
<item>
<title>FY26 Half Year Results Announcement</title>
<link>https://6ix.com/company/veris-ltd/news/fy26-half-year-results-announcement-6</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/fy26-half-year-results-announcement-6</guid>
<pubDate>Tue, 24 Feb 2026 02:34:32 GMT</pubDate>
<description>FY26 Half Year Results Announcement</description>
</item>
<item>
<title>Therma-Tru Announces Award Wins for Its New Veris Modern Grain Entryways</title>
<link>https://6ix.com/company/veris-ltd/news/therma-tru-announces-award-wins-for-its-new-veris-modern-grain-entryways-1</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/therma-tru-announces-award-wins-for-its-new-veris-modern-grain-entryways-1</guid>
<pubDate>Thu, 18 Dec 2025 21:11:00 GMT</pubDate>
<description>DEERFIELD, Ill., December 18, 2025--Therma-Tru’s Veris Modern Grain entryway system has recently earned industry recognition, reinforcing modern style, beauty and enduring performance.</description>
</item>
<item>
<title>Veris Completes Acquisition of Mesh & Investment in Parsel</title>
<link>https://6ix.com/company/veris-ltd/news/veris-completes-acquisition-of-mesh-and-investment-in-parsel</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/veris-completes-acquisition-of-mesh-and-investment-in-parsel</guid>
<pubDate>Tue, 02 Dec 2025 02:45:13 GMT</pubDate>
<description>Veris Completes Acquisition of Mesh & Investment in Parsel</description>
</item>
<item>
<title>PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/veris-ltd/news/pavmed-provides-business-update-and-reports-third-quarter-2025-financial-results-1</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/pavmed-provides-business-update-and-reports-third-quarter-2025-financial-results-1</guid>
<pubDate>Thu, 13 Nov 2025 13:00:00 GMT</pubDate>
<description>PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and reported financial results for the quarter ended September 30, 2025.</description>
</item>
<item>
<title>2025 AGM Presentation including Q1 Update</title>
<link>https://6ix.com/company/veris-ltd/news/2025-agm-presentation-including-q1-update</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/2025-agm-presentation-including-q1-update</guid>
<pubDate>Tue, 21 Oct 2025 02:55:11 GMT</pubDate>
<description>2025 AGM Presentation including Q1 Update</description>
</item>
<item>
<title>Acquisition of Mesh & Investment in Parsel Digital Platform</title>
<link>https://6ix.com/company/veris-ltd/news/acquisition-of-mesh-and-investment-in-parsel-digital-platform</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/acquisition-of-mesh-and-investment-in-parsel-digital-platform</guid>
<pubDate>Mon, 20 Oct 2025 01:41:09 GMT</pubDate>
<description>Acquisition of Mesh & Investment in Parsel Digital Platform</description>
</item>
<item>
<title>PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership Agreement</title>
<link>https://6ix.com/company/veris-ltd/news/pavmed-subsidiary-veris-health-and-the-ohio-state-university-comprehensive-cancer-center-launch-commercial-phase-of-strategic-partnership-agreement</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/pavmed-subsidiary-veris-health-and-the-ohio-state-university-comprehensive-cancer-center-launch-commercial-phase-of-strategic-partnership-agreement</guid>
<pubDate>Tue, 07 Oct 2025 12:01:00 GMT</pubDate>
<description>PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital health subsidiary Veris Health Inc. ("Veris"), today announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), a National Cancer Institute (NCI)-Designated Comprehensi</description>
</item>
<item>
<title>FY25 Results Investor Presentation</title>
<link>https://6ix.com/company/veris-ltd/news/fy25-results-investor-presentation-23</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/fy25-results-investor-presentation-23</guid>
<pubDate>Tue, 26 Aug 2025 02:28:49 GMT</pubDate>
<description>FY25 Results Investor Presentation</description>
</item>
<item>
<title>FY25 Results Announcement</title>
<link>https://6ix.com/company/veris-ltd/news/fy25-results-announcement-59</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/fy25-results-announcement-59</guid>
<pubDate>Tue, 26 Aug 2025 02:28:49 GMT</pubDate>
<description>FY25 Results Announcement</description>
</item>
<item>
<title>2025 Appendix 4E</title>
<link>https://6ix.com/company/veris-ltd/news/2025-appendix-4e-2</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/2025-appendix-4e-2</guid>
<pubDate>Tue, 26 Aug 2025 02:27:18 GMT</pubDate>
<description>2025 Appendix 4E</description>
</item>
<item>
<title>PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/veris-ltd/news/pavmed-provides-business-update-and-reports-second-quarter-2025-financial-results-1</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/pavmed-provides-business-update-and-reports-second-quarter-2025-financial-results-1</guid>
<pubDate>Thu, 14 Aug 2025 12:00:00 GMT</pubDate>
<description>PAVmed Inc. (NASDAQ: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and reported financial results for the quarter ended June 30, 2025.</description>
</item>
<item>
<title>On-market Buy-Back Renewal</title>
<link>https://6ix.com/company/veris-ltd/news/on-market-buy-back-renewal</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/on-market-buy-back-renewal</guid>
<pubDate>Mon, 04 Aug 2025 02:41:21 GMT</pubDate>
<description>On-market Buy-Back Renewal</description>
</item>
<item>
<title>VRS Confirms Return to Profitability - FY25 Unaudited Result</title>
<link>https://6ix.com/company/veris-ltd/news/vrs-confirms-return-to-profitability-fy25-unaudited-result</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/vrs-confirms-return-to-profitability-fy25-unaudited-result</guid>
<pubDate>Thu, 24 Jul 2025 02:39:29 GMT</pubDate>
<description>VRS Confirms Return to Profitability - FY25 Unaudited Result</description>
</item>
<item>
<title>Veris Awarded $16-$20m Suburban Rail Loop Contract</title>
<link>https://6ix.com/company/veris-ltd/news/veris-awarded-dollar16-dollar20m-suburban-rail-loop-contract</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/veris-awarded-dollar16-dollar20m-suburban-rail-loop-contract</guid>
<pubDate>Mon, 21 Jul 2025 03:28:23 GMT</pubDate>
<description>Veris Awarded $16-$20m Suburban Rail Loop Contract</description>
</item>
<item>
<title>PAVmed Subsidiary Veris Health Completes $2.5 Million Direct Equity Financing</title>
<link>https://6ix.com/company/veris-ltd/news/pavmed-subsidiary-veris-health-completes-dollar25-million-direct-equity-financing</link>
<guid isPermaLink="true">https://6ix.com/company/veris-ltd/news/pavmed-subsidiary-veris-health-completes-dollar25-million-direct-equity-financing</guid>
<pubDate>Tue, 24 Jun 2025 12:01:00 GMT</pubDate>
<description>PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiary, Veris Health Inc. ("Veris"), today announced the completion of a private placement equity financing directly into Veris, yielding $2.5 million in proceeds (gross and net). This supplements a prior $2.4 million financing completed earlier this year.</description>
</item>
</channel>
</rss>